Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 238

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 238
---
 by or on behalf of any underwriter through BofA specifically for inclusion therein. Further, the underwriting agreement contains a contribution provision in the event the indemnification obligations described above are unavailable or otherwise prohibited by law. The contribution obligations of the underwriters under the underwriting agreement are limited to the total underwriting discounts and commissions paid, in the aggregate, by APx to the underwriters upon the consummation of the IPO, and the underwriters otherwise have no further contribution liability under the underwriting agreement with respect to the Business Combination with the Company because BofA waived its rights to any deferred underwriting discounts with respect to the Business Combination with the Company. Therefore, in contrast to other transactions where the underwriters did not waive rights to fees or deferred underwriting discounts, as the case may be, the potential financial liability of APx with respect to an indemnified loss where such indemnification is otherwise unavailable to the indemnified party may be higher under the respective agreements than it would have been had BofA not refused to serve and waived their rights to any fees or deferred underwriting discounts. Other than the foregoing indemnification and contribution obligations or the payment of the deferred compensation in connection with an alternative business combination, APx has no further obligations to BofA under the underwriting agreement with respect to the Business Combination with the Company, and no obligations relating to the Business Combination with the Company. BofA declined to act for APx as an advisor in connection with the Business Combination, and BofA has had no role in the preparation of the disclosure that is included in this proxy statement / prospectus, or the underlying business analysis related to the Business Combination. As described above, BofA declined to serve in any capacity in connection with the Business Combination with the Company and agreed to waive its deferred compensation relating to the IPO in connection with the Business Combination with the Company. Accordingly, BofA has not been involved in the Business Combination with the Company, the preparation of any disclosure that is included in this proxy statement/prospectus, or any business analysis underlying such disclosure, and shareholders do not have the benefit of any such involvement. Shareholders and investors should not place any reliance on the fact that BofA was previously involved in the IPO. 98 Unaudited Pro Forma Combined Financial Information Introduction OmnigenicsAI is providing the following unaudited pro forma combined financial information to aid you in your analysis of the financial aspects of the Transactions. The following unaudited pro forma combined statements of financial position